176 related articles for article (PubMed ID: 36015306)
1. Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment.
Żuk M; Podgórski R; Ruszczyńska A; Ciach T; Majkowska-Pilip A; Bilewicz A; Krysiński P
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015306
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy.
Żuk M; Gawęda W; Majkowska-Pilip A; Osial M; Wolski M; Bilewicz A; Krysiński P
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834258
[TBL] [Abstract][Full Text] [Related]
3. Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with
Cędrowska E; Pruszyński M; Gawęda W; Żuk M; Krysiński P; Bruchertseifer F; Morgenstern A; Karageorgou MA; Bouziotis P; Bilewicz A
Molecules; 2020 Feb; 25(5):. PubMed ID: 32106568
[TBL] [Abstract][Full Text] [Related]
4. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
5.
Gharibkandi NA; Żuk M; Muftuler FZB; Wawrowicz K; Żelechowska-Matysiak K; Bilewicz A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982357
[TBL] [Abstract][Full Text] [Related]
6. Au@
Gharibkandi NA; Wawrowicz K; Majkowska-Pilip A; Żelechowska-Matysiak K; Wierzbicki M; Bilewicz A
EJNMMI Radiopharm Chem; 2023 Oct; 8(1):26. PubMed ID: 37821747
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles.
Żelechowska-Matysiak K; Salvanou EA; Bouziotis P; Budlewski T; Bilewicz A; Majkowska-Pilip A
Mol Pharm; 2023 Sep; 20(9):4676-4686. PubMed ID: 37607353
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab-Modified Gold Nanoparticles Labeled with
Dziawer Ł; Majkowska-Pilip A; Gaweł D; Godlewska M; Pruszyński M; Jastrzębski J; Wąs B; Bilewicz A
Nanomaterials (Basel); 2019 Apr; 9(4):. PubMed ID: 31003512
[TBL] [Abstract][Full Text] [Related]
9. Lanthanide-Doped SPIONs Bioconjugation with Trastuzumab for Potential Multimodal Anticancer Activity and Magnetic Hyperthermia.
Gawęda W; Osial M; Żuk M; Pękała M; Bilewicz A; Krysinski P
Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32046284
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers.
Żelechowska-Matysiak K; Wawrowicz K; Wierzbicki M; Budlewski T; Bilewicz A; Majkowska-Pilip A
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985421
[TBL] [Abstract][Full Text] [Related]
11. Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells.
Kagawa T; Matsumi Y; Aono H; Ohara T; Tazawa H; Shigeyasu K; Yano S; Takeda S; Komatsu Y; Hoffman RM; Fujiwara T; Kishimoto H
Cell Cycle; 2021 Jul; 20(13):1221-1230. PubMed ID: 34148497
[TBL] [Abstract][Full Text] [Related]
12. Bifunctional magnetopolymersomes of iron oxide nanoparticles and carboxymethylcellulose conjugated with doxorubicin for hyperthermo-chemotherapy of brain cancer cells.
Carvalho SM; Leonel AG; Mansur AAP; Carvalho IC; Krambrock K; Mansur HS
Biomater Sci; 2019 Apr; 7(5):2102-2122. PubMed ID: 30869664
[TBL] [Abstract][Full Text] [Related]
13. Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy.
Gawęda W; Pruszyński M; Cędrowska E; Rodak M; Majkowska-Pilip A; Gaweł D; Bruchertseifer F; Morgenstern A; Bilewicz A
Nanomaterials (Basel); 2020 Oct; 10(10):. PubMed ID: 33092037
[TBL] [Abstract][Full Text] [Related]
14. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
[TBL] [Abstract][Full Text] [Related]
15.
Ognjanović M; Radović M; Mirković M; Prijović Ž; Puerto Morales MD; Čeh M; Vranješ-Đurić S; Antić B
ACS Appl Mater Interfaces; 2019 Nov; 11(44):41109-41117. PubMed ID: 31610125
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
17. Fe
Lu Q; Dai X; Zhang P; Tan X; Zhong Y; Yao C; Song M; Song G; Zhang Z; Peng G; Guo Z; Ge Y; Zhang K; Li Y
Int J Nanomedicine; 2018; 13():2491-2505. PubMed ID: 29719396
[TBL] [Abstract][Full Text] [Related]
18. The Effects of a Varied Gold Shell Thickness on Iron Oxide Nanoparticle Cores in Magnetic Manipulation, T
Brennan G; Bergamino S; Pescio M; Tofail SAM; Silien C
Nanomaterials (Basel); 2020 Dec; 10(12):. PubMed ID: 33291591
[TBL] [Abstract][Full Text] [Related]
19. Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with
Ünak P; Yasakçı V; Tutun E; Karatay KB; Walczak R; Wawrowicz K; Żelechowska-Matysiak K; Majkowska-Pilip A; Bilewicz A
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986710
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
